Galera Therapeutics (QB)【GRTX】銘柄情報

Galera Therapeutics Inc (QB) (GRTX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.0881

( -1.01% )

買値

0.0001

売値

2,000.00

出来高

41,513

平均取引量 (3 か月)

US$ 313,991

財務取引量

US$ 3,851

0.0881 日の範囲 0.095

0.0151 52 週間の範囲 0.15

時価総額

14.134M

企業価値

13.474M

前日終値

0.089

始値

0.0881

時刻

0.1

最終取引時間

VWAP

0.092777

歳入

純利益

149.04M

発行済株式数

160,429,783

浮動株比率 (%)

35.78%

機関投資家保有比率 (%)

8.84%

配当利回り

PER

0.14

株価売上高倍率 (PSR)

1 株当たり利益 (EPS)

0.64

ベータ

2.61

Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company’s lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat pa... Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company’s lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat patients with highly resistant forms of breast cancer, including metaplastic breast cancer (MpBC) and other refractory subsets of triple-negative breast cancer (TNBC). It develops avasopasem manganese, a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC). The company was incorporated in 2012 and is based in Malvern, Pennsylvania. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.galeratx.com

本社

Malvern, United States

設立

2026

Galera Therapeutics Inc (QB) is listed in the Healthcare sector of the その他OTC with ticker GRTX. The last closing price for Galera Therapeutics (QB) was US$0.09. Over the last year, Galera Therapeutics (QB) shares have traded in a share price range of US$ 0.0151 to US$ 0.15.

Galera Therapeutics (QB) currently has 160,429,783 shares in issue. The market capitalisation of Galera Therapeutics (QB) is US$14.13 million. Galera Therapeutics (QB) has a price to earnings ratio (PE ratio) of 0.14.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0001	0.113636363636	0.088	0.095	0.088	20435	0.08875433	CS
4	-0.0019	-2.11111111111	0.09	0.095	0.0838	88831	0.08947117	CS
12	0.0061	7.43902439024	0.082	0.119	0.0795	140767	0.09403199	CS
26	0.06466	275.853242321	0.02344	0.15	0.0211	191663	0.07831469	CS
52	0.06125	228.119180633	0.02685	0.15	0.0151	143960	0.05852399	CS
156	-0.0427	-32.6452599388	0.1308	0.15	0.0151	193057	0.06887497	CS
260	-0.0427	-32.6452599388	0.1308	0.15	0.0151	193057	0.06887497	CS